Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications

Sanquin Blood Bank Southwest Region, Leiden, Netherlands.
Critical care medicine (Impact Factor: 6.31). 10/2009; 38(2):546-52. DOI: 10.1097/CCM.0b013e3181c0de7b
Source: PubMed


To investigate whether the higher prevalence of postoperative complications in cardiac surgery after transfusion of leukocyte-containing red blood cells can be related to inflammatory mediators.
Analysis of inflammatory markers interleukin-6, interleukin-10, interleukin-12, and procalcitonin in patients participating in a randomized trial comparing leukocyte-depleted with leukocyte-containing, buffy-coat-depleted red blood cells.
Two university-affiliated hospitals in the Netherlands.
A total of 346 patients undergoing cardiac valve surgery with a complete series of pre- and postoperative blood samples.
There were no differences in the cytokines and procalcitonin concentrations between both study arms when the patients arrived in the intensive care unit. In subgroups, patients who received zero to three red blood cell transfusions showed similar cytokine concentrations in both study arms, whereas patients with > or = 4 red blood cell transfusions had significantly higher interleukin-6 concentrations in the leukocyte-containing, buffy-coat-depleted red blood cell group. Patients who developed postoperative infections and multiple organ dysfunction syndrome showed, respectively, increased concentrations of interleukin-6 and interleukin-12 in the leukocyte-containing, buffy-coat-depleted, red blood cell group. The interaction tests in these subgroups showed significantly different reaction patterns in the leukocyte-containing, buffy-coat-depleted red blood cell group compared with leukocyte-depleted red blood cell group for interleukin-6 and interleukin-12. Multivariate analysis showed a high interleukin-6 concentration with multiple organ dysfunction syndrome and both high interleukin-6 and interleukin-10 concentrations with hospital mortality.
Allogeneic leukocyte-containing blood transfusions compared with leukocyte-depleted blood transfusions induce dose-dependent significantly higher concentrations of proinflammatory mediators in the immediate postoperative period after cardiac surgery. High concentrations of interleukin-6 are strong predictors for development of multiple organ dysfunction syndrome, whereas both interleukin-6 and interleukin-10 are associated with hospital mortality. These findings suggest that leukocyte-containing red blood cells interfere with the balance between postoperative proinflammatory response, which may further affect the development of complications after cardiac surgery.

Download full-text


Available from: YM Bilgin, Oct 05, 2015
12 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To begin, we must agree on what we mean by a learning system and a learning control system. A system is called learning if the information pertaining to the unknown features of a process or its environment is acquired by the system, and the obtained experience is used for future estimation, recognition, classification, decision or control such that the performance of the system will be improved. A learning system is called a learning control system if the acquired information is used to control a process with unknown features (these standardized definitions are taken from Reference 1). The attribute of "learning" that is associated with learning systems, derives from psychological learning theories, especially reinforcement learning theories.
    Decision and Control including the 13th Symposium on Adaptive Processes, 1974 IEEE Conference on; 01/1974
  • Critical care medicine 02/2010; 38(2):720-1. DOI:10.1097/CCM.0b013e3181c5867f · 6.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The past two decades have witnessed an extensive re-evaluation of transfusion therapy in the intensive care unit (ICU). The purpose of this review is to present the current state of knowledge regarding blood transfusion in the critically ill and to identify gaps in our current understanding for future research. Accumulating evidence suggests a lack of efficacy with red blood cell (RBC), plasma, and platelet transfusion in the majority of critically ill patients. Evidence has also increasingly exposed previously under-recognized transfusion risks. The result is a growing number of recommendations for more restrictive RBC, plasma, and platelet transfusion strategies. An important exception to a more conservative transfusion practice occurs in patients with major trauma and life-threatening bleeding. Delaying RBCs, plasma and platelet component therapies in this population can promote the lethal triad of coagulopathy, acidosis, and hypothermia with a resultant increase in bleeding, greater transfusion requirements, and higher mortality. Although we have made substantial progress in understanding the role of blood transfusion in the ICU, multiple important knowledge gaps persist. Future studies are needed to better define and characterize the impact of RBC storage, male-only plasma and platelet donor procurement procedures, and transfusion strategies in those requiring massive transfusion and with acute local or global tissue ischemia.
    Current opinion in critical care 08/2010; 16(4):309-16. DOI:10.1097/MCC.0b013e32833bc4a4 · 2.62 Impact Factor
Show more